Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): Experience in an Iranian population

BMC Dermatology

Volumn 5, Issue , 2005, Pages

  Aghaei, Shahin ^a  

^a JAHROM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHENCYPRONE;

ADOLESCENT; ADULT; ALOPECIA AREATA; ARTICLE; BULLOUS SKIN DISEASE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTACT URTICARIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG RESPONSE; DRUG SENSITIZATION; DRUG TOLERABILITY; ERYTHEMA; FEMALE; FOLLOW UP; HAIR GROWTH; HUMAN; HYPERPIGMENTATION; HYPOPIGMENTATION; IMMUNOTHERAPY; IRAN; LYMPHADENOPATHY; MAINTENANCE THERAPY; MALE; POPULATION RESEARCH; PRURITUS; RECURRENT DISEASE; REMISSION; SCHOOL CHILD; VITILIGO;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ALOPECIA AREATA; CHILD; CYCLOPROPANES; DERMATOLOGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HAIR; HUMANS; IMMUNOTHERAPY; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 25444518265     PISSN: 14715945     EISSN: 14715945     Source Type: Journal    
DOI: 10.1186/1471-5945-5-6     Document Type: Article

References (28)

1. Fiedler VC, Alaiti S. Treatment of alopecia areata. Dermatol Clin 1996; 14: 733-8.
2. Fiedler VC. Alopecia areata: a review of therapy, efficacy, safety and mechanism. Arch Dermatol 1992; 128:1519-29.
3. Schwartz RA, Jonninger CK. Alopecia areata. Cutis 1997; 59: 238-41.
4. Shapiro J. Alopecia areata: Update on therapy. Dermatol Clin 1993; 11: 35-46.
5. Olsen EA, Carson SC, Turney EA. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. Arch Dermatol 1992; 128: 1467-73.
6. Schmoeckel C, Weissman I, Pelwig G, Braun-Falco O. Treatment of alopecia areata by anthralin-induced dermatitis. Arch Dermatol 1979; 115: 1254-5.
7. Fiedler-Weiss VC, Buys CM. Evaluation of anthralin in the treatment of alopecia areata. Arch Dermatol 1987; 123: 1491-3.
8. Fiedler VC, Wendrow A, Szpunar GJ, Metzier C, De Villez RL. Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin. Arch Dermatol 1990; 126: 756-9.
9. Fiedler-Weiss VC. Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata. J Am Acad Dermatol 1987; 16: 745-8.
10. Gupta AK, Ellis CN, Cooper KD, Nickoloff BJ, Ho VC, Chan LS, Hamilton TA, Tellner DC, Griffiths CE, Voorhees JJ. Oral cyclosporine for treatment of alopecia areata. A clinical and immunohistochemical analysis. J Am Acad Dermatol 1990; 22: 242-50.
11. Gilhar A, Pillar T, Etzioni A. Topical cyclosporine A in alopecia areata. Acta Derm Venereol (Stockh) 1989; 69: 252-3.
12. de Prost Y, Teillac D, Paquez F, Carrugi L, Bachelez H, Touraine R. Placebo-controlled trials of topical cyclosporine in severe alopecia areata. Lancet 1986; ii: 803-4.
13. Magee KL, Hsu SM, Tucker SB. Trial of intralesional interferon-alpha in the treatment of alopecia areata. Arch Dermatol 1990; 126: 760-2.
14. Ge S. Treatment of alopecia areata with acupuncture. J Trad Chinese Med 1990; 10: 199-200.
15. Daman L, Rosenberg W, Drake L. Treatment of alopecia areata with DNCB. Arch Dermatol 1978; 114: 1036-8.
16. Happle R, Kalveran KJ, Buchner U, Echternacht-Happle K, Goggelmann W, Summer KH. Contact allergy as a therapeutic tool for alopecia areata: application of squaric acid dibutylester. Dermatologica 1980; 161: 289-97.
17. Happle R, Hansen BM, Wiesner-Menzel L. Diphenylcyclopropenone in the treatment of alopecia areata. Acta Derm Venereol (Stockh) 1983; 63: 49-52.
18. Cotellessa C, Peris K, Caracciolo E. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata. J Am Acad Dermatol 2001; 44: 73-6.
19. Simonetti O, Lucarini G, Bernardini ML, Simoncini C, Biagini G, and Offidani A. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study. Br J Dermatol. 2004; 150: 940-948.
20. Tang L, Lui H, Sundberg JP, Bissonnette R, McLean DI, and Shapiro J. Restoration of hair growth with topical diphencyprone in mouse and rat models of alopecia areata. J Am Acad Dermatol. 2003 Dec; 49(6):1013-9.
21. Weise K, Kretzschmar L, John SM, Hamm H. Topical immunotherapy in alopecia areata: anamnestic and clinical criteria of prognostic significance. Dermatology 1996; 92: 129-33.
22. Van der Steen PHM, Boezeman JBM, Happle R. Topical immunotherapy for alopecia areata: Re-evaluation of 139 cases after an additional follow-up of 19 months. Dermatology 1992; 184: 198-201.
23. Hausen BM, Stute J. Diphenylcyclopropenone: a strong contact sensitizer. Chem Industry 1980; 17: 699-700.
24. Kietzmann H, Hardung H, Christophers E. Terapie der alopecia areata mit Diphenylcyclopropenon. Hautarzt 1985; 36: 331-5 [Abstract].
25. Gordon PM, Aldridge RD, McVittie E, Hunter JAA. Topical diphencyprone for alopecia areata: evaluation of 48 cases after 30 months' follow-up. Br J Dermatol 1996; 134: 869-71.
26. Wiseman MC, Shapiro J, McDonald N, Lui H. Predictive model for immunotherapy of alopecia areata with diphencyprone. Arch Dermatol. 2001; 137: 1063-1068.
27. Happle R. Diphencyprone for the treatment of alopecia areata. Arch Dermatol. 2002: 138: 112-113.
28. Van der Steen PHM, Van Baar HJM, Perret CM, Happle R. Treatment of alopecia areata with diphenylcyclopropenone. J Am Acad Dermatol 1991; 24: 253-7.